Fulgent Genetics(us:FLGT)

16.90

-0.88%

Updated on 2025-03-31

Open:16.90
Close:16.90
High:17.19
Low:16.57
Prev Close:17.05
Volume:305860.00
Turnover:5.19M
Turnover Ratio:0.99%
Shares:30.87M
MarketCap:521.63M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30940050.01%142
2024-03-312101463863948.98%264997
2023-12-312211430180548.23%2752102
2023-09-302261403543446.73%225995
2023-06-302381375565845.98%2944117
2023-03-312301337987245.06%207189
2022-12-312561309661644.49%3262116
2022-09-302711319653244.46%2085110
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Blackrock Inc.392108512.96%5470.01%
2024-06-30Vanguard Group Inc14354254.74%109770.77%
2024-06-30Dimensional Fund Advisors Lp12162284.02%-128791-9.57%
2024-06-30Millennium Management Llc9588523.17%24498134.32%
2024-06-30Park West Asset Management Llc8333692.75%10358614.19%
2024-06-30State Street Corp7826772.59%-41800-5.07%
2024-06-30Divisadero Street Capital Management, Lp5052121.67%16021246.44%
2024-06-30Geode Capital Management, Llc4895491.62%171683.63%
2024-06-30Morgan Stanley3691331.22%14888567.60%
2024-06-30Ameriprise Financial Inc3547251.17%-5410-1.50%

About

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Address:4399 Santa Anita Avenue

Market Movers